In atherosclerosis, vascular smooth muscle cells (VSMC) migrate from the media toward the intima of the arteries in response to cytokines, such as platelet-derived growth factor (PDGF). However, molecular mechanism underlying the PDGF-induced migration of VSMCs remains unclear. The migration of rat aorta-derived synthetic VSMCs, A7r5, in response to PDGF was potently inhibited by a Ca V 1.2 channel inhibitor, nifedipine, and a Src family tyrosine kinase (SFK)/Abl inhibitor, bosutinib, in a less-than-additive manner. PDGF significantly increased Ca V 1.2 channel currents without altering Ca V 1.2 protein expression levels in A7r5 cells. This reaction was inhibited by C-terminal Src kinase, a selective inhibitor of SFKs. In contractile VSMCs, the C-terminus of Ca V 1.2 is proteolytically cleaved into proximal and distal C-termini (PCT and DCT, respectively). Clipped DCT is noncovalently reassociated with PCT to autoinhibit the channel activity. Conversely, in synthetic A7r5 cells, full-length Ca V 1.2 (Ca V 1.2FL) is expressed much more abundantly than truncated Ca V 1.2. In a heterologous expression system, c-Src activated Ca V 1.2 channels composed of Ca V 1.2FL but not truncated Ca V 1.2 (Ca V 1.2Δ1763) or Ca V 1.2Δ1763 plus clipped DCT. Further, c-Src enhanced the coupling efficiency between the voltage-sensing domain and activation gate of Ca V 1.2FL channels by phosphorylating Tyr1709 and Tyr1758 in PCT. Compared with Ca V 1.2Δ1763, c-Src could more efficiently bind to and phosphorylate Ca V 1.2FL irrespective of the presence or absence of clipped DCT. Therefore, in atherosclerotic lesions, phenotypic switching of VSMCs may facilitate pro-migratory effects of PDGF on VSMCs by suppressing posttranslational Ca V 1.2 modifications.
Introduction
Despite recent improvements in life style and advances in pharmacotherapy, atherosclerosis remains to be a cause of various cardiovascular diseases, such as ischemic heart diseases, which are the leading cause of death in developed nations. Therefore, it is necessary to further explore the pathophysiology of atherosclerosis.
In the presence of atherosclerotic risk factors, such as hypercholesterolemia, the initial lesions of atherosclerosis are formed as Bfatty streaks,^in which circulating monocytes and T lymphocytes invade the sub-endothelial intimal layer of the large and medium arteries [20] . Macrophages derived from these monocytes secrete various cytokines, such as platelet-derived growth factor (PDGF). These cytokines cause a phenotypical switching of vascular smooth muscle cells (VSMC) from Bcontractile^to Bsynthetict ypes. Further, PDGF potently induces the migration of synthetic VSMCs from the media into the intima of the arteries [25] . Synthetic VSMCs in the intima proliferate and efficiently secrete extracellular matrix, pathologically narrowing the vascular lumen, thereby leading to cardiovascular complications.
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Isolation of tissues
Rats were anesthetized and euthanized by exsanguination. The hearts were immediately excised and immersed in icecold modified Tyrode solution containing (mM) 136.5 NaCl (Wako Pure Chemical Industries, Osaka, Japan), 5.4 KCl (Wako), 1.8 CaCl 2 (Wako), 0.53 MgCl 2 (Wako), 5.5 HEPES (Dojindo, Kumamoto, Japan), and 5.5 glucose (Wako) (pH 7.4 with NaOH). The aorta and cerebral arteries were carefully dissected from the thorax and brain, respectively, and rinsed with the modified Tyrode solution.
Cell cultures
A7r5 smooth muscle cells derived from the rat thoracic aorta (American Type Culture Collection, Manassas, VA, USA) and tsA201 human embryonic kidney cells (European Collection of Authenticated Cell, Salisbury, UK) were cultured in the high-glucose (4.5 g/l) and low-glucose (1 g/l) Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% fetal bovine serum (FBS, Sigma-Aldrich Japan, Tokyo, Japan), 100 units/ml penicillin (Thermo Fisher Scientific, Waltham, MA, USA), and 100 μg/ml streptomycin (Thermo), respectively, at 37°C and 5% CO 2 .
Plasmid construction
cDNA encoding a rat smooth muscle Ca V 1.2 (B8 clone) was kindly provided by Dr. Tuck Wah Soong (National University of Singapore, Singapore, Singapore) [30] . Ca V 1.2Δ1763 [Ca V 1.2 subunit lacking a distal C-terminus 1764-2140 (DCT)] was generated using PCR. For the plasmid construction of HA-tagged Ca V 1.2 and HA-Ca V 1.2Δ1763, an HA-epitope was inserted into N-termini using a sense primer containing a sequence coding HA-epitope tag and BamHI site. The PCR products were subcloned into a blunt-ended pBlueScript SK-vector and subcloned again into the BamHI sites of Ca V 1.2 sequence and plasmid multi-cloning sites. To generate 3xFLAG-tagged Ca V 1.2 DCT, cDNA encoding amino acids 1764-2140 of Ca V 1.2 was PCR-amplified and subcloned into p3xFLAG-CMV-10 (Sigma-Aldrich). Other cDNA included in the rat or mouse heart cDNA library were isolated using RT-PCR and were subcloned into pcDNA3.1 or pCMV-Myc (Clontech Laboratories, Mountain View, CA, USA) as previously reported [17, 28] . Single or multi-amino acid substitution mutants of Ca V 1.2 with their tyrosine residues of the C-terminus substituted with phenylalanine residues (Fig. 5) were generated using the QuickChange Site-Directed Mutagenesis Kit (Stratagene, Agilent Technologies, Tokyo, Japan) according to manufacturer's instructions.
Wound healing assay
A7r5 cells in collagen-coated 24-well plates were wounded by dragging a sterile 200 μl pipette tip (Labcon, Petaluma, CA, USA) across 100% confluent monolayers to create cell-free area. Then, the cells were treated with deionized water (control) or PDGF-BB (10 ng/ml, Bachem, Torrance, CA, USA) in the presence or absence of pharmacological inhibitors in serum-free DMEM for 48 h. The cells were fixed in 4% paraformaldehyde in phosphate-buffered saline for 15 min and stained with phalloidin-tetramethylrhodamine B isothiocyanate (1 μg/ml, Sigma-Aldrich) and Hoechst 33342 (0.5 μg/ml, Sigma-Aldrich). Fluorescence images were acquired and digitized using an inverted fluorescent microscope (Zeiss Axio Observer Z1, Carl Zeiss, Jena, Germany). The extent of wound healing was evaluated as the ratio of the number of pixels of a healed area to that of the original wound area using a contrast adjustment configuration in the ImageJ software (NIH, MD, USA).
Ca

2+ imaging
A7r5 cells plated to~50% confluency on collagen-coated glass bottom 35-mm dishes were cultured in serum-free DMEM for 48 h to induce growth arrest, and the cells were treated with deionized water (control) or 10 ng/ml PDGF-BB for 24 h. Then, the samples were incubated with 2 μM Fluo-4/ AM (Dojindo) plus 0.01% Cremophore EL (Sigma-Aldrich) and 0.02% BSA (Sigma-Aldrich) in serum-free DMEM for 30 min at 37°C and 5% CO 2 . ] i ) change, the increment in fluorescence intensity normalized to baseline fluorescence intensity (ΔF/ F 0 ) was calculated.
Electrophysiology
A7r5 cells were grown to~70% confluency in plastic dishes and transiently transfected with cDNA for enhanced green fluorescent protein (EGFP, 0.1 μg plasmid DNA/35-mm dish) plus mock or C-terminal Src kinase (CSK) cDNA (1.0 μg plasmid DNA/35-mm dish) with Lipofectamine 2000 (Thermo). The cultures were maintained in a serum-free condition for 48 h. Then, the transfected cells were treated with vehicle (deionized water) or 10 ng/ml PDGF-BB for 24 h. Finally, the cells were detached and re-plated onto coverslips at a low density in serum-free DMEM for 2 h before measuring Ca V 1.2 channel currents.
TsA201 cells were grown to~70% confluency in plastic dishes and transiently transfected with an equimolar ratio of cDNA encoding wild-type or mutant Ca V 1.2α 1C , β 2a , and α 2 δ 1 subunits (1.0, 0.7, and 0.8 μg of plasmid DNA/35-mm dish, respectively); a 10-fold lower concentration of cDNA for EGFP; and cDNA for other proteins with polyethylenimine (4 μg/ml, Polysciences, Inc., Warrington, PA). The cultures were maintained in a serum-free condition for 48 h. Then, the cells were detached and re-plated onto collagencoated coverslips at a low density in serum-free DMEM for 24 h.
Ionic currents of Ca V 1. The relationship between the current density and voltage of Ca V 1.2 channels was analyzed according to the standard voltage protocol. The peak of Ca V 1.2 channel Ba 2+ current density (pA/pF) was calculated by dividing the peak channel current amplitude by the cell membrane capacitance and plotted against the membrane potentials. The liquid junction potential of + 20 mV between these pipette and bath solutions was corrected in the membrane potentials indicated in the following descriptions.
The coupling efficiency between the VSD and AG of recombinant Ca V 1.2 channels was assessed in EGFP-positive tsA201 cells with the above pipette and bath solutions as follows: (1) first, the membrane potential was depolarized from the holding potential of − 80 mV to potentials between + 50 and + 80 mV for 25 ms with a 2-mV increment and then repolarized to − 70 mV for 10 ms every 5 s; (2) then, the gating charge was measured by integrating the ON gating current at the apparent reversal potential of Ca V 1.2 currents (E rev ) for initial 2 ms; and (3) finally, the coupling efficiency was assessed by calculating the ratio of the tail Ba 2+ current amplitude upon repolarization from E rev to − 70 mV to the ON gating charge at E rev [17] .
The relationship between the current density and voltage of recombinant Ca V 
D _peak , peak current density; G max , maximum conductance density; E 0.5_Act , half-maximum activation potential; E m , membrane potential; and k _Act , slope factor of activation. From E 0.5_Act and k _Act , the activation curve of recombinant Ca V 1.2 channels was depicted using the Delta Graph software (Pantone Inc., NJ, USA). The steady-state inactivation of recombinant Ca V 1.2 channels was assessed according to the standard doublepulse protocol, and the peak Ca V 1.2 channel Ca 2+ current amplitude in P2 normalized to the maximum was plotted against P1 membrane potentials and fit into the following equation (Table 1) :
f, availability; f 0 , an offset at depolarized potential; E 0.5_Inact , half-maximum inactivation potential; and k _Inact , slope factor of inactivation.
Immunoblotting and immunoprecipitation
Immunoblotting and immunoprecipitation were performed as previously described [17] . Briefly, microsomes were obtained from isolated tissues and cells. Samples were lysed with icecold lysis buffer with 10 mM Tris (pH 7.5), 150 mM NaCl, 1% Triton-X (Sigma-Aldrich), and 10% glycerol (Wako) containing a protease inhibitor cocktail and a phosphatase inhibitor cocktail (Nacalai tesque, Kyoto, Japan). For immunoprecipitation of HA-Ca V 1.2, lysates (125-250 μg/lane) containing HA-antibody (MBL, Nagoya, Japan) (3 μg) were incubated with Protein A-Sepharose (GE Healthcare Japan, Tokyo, Japan), and the immunoprecipitates were washed with the lysis buffer. For immunoblotting, samples were separated on SDS-PAGE using 4-15% gradient gels. Primary and secondary antibodies against the following proteins were used: Ca 
Proximity ligation assay and immunocytochemistry
A proximity ligation assay (PLA) was performed using the Duolink system (Sigma-Aldrich) in tsA201 cells cotransfected with cDNA for Ca V 1.2 channel subunits plus that for Myc-cSrc according to the manufacturer's instructions. Antibodies against Ca V 1.2 (1:200, Alomone) and Myc (1:2000, MBL) were used as primary antibodies. Signals were visualized using Duolink In Situ PLA Probe Anti-Mouse PLUS, Duolink In Situ PLA Probe Anti-Rabbit MINUS, and Duolink In Situ Detection Reagents Orange (SigmaAldrich). Slides were mounted with Duolink In Situ Mounting Medium and DAPI (Sigma-Aldrich). Z-stack images of the cells (pinhole size: 1 airy unit) were acquired using a laser scanning microscope TCS SP8 (Leica Microsystems), and the images were merged using the maximum projection G max maximum conductance density, E 0.5_Act half-maximum activation potential, k Act slope factor of activation, E rev apparent reversal potential, f 0 an offset at depolarized potential, E 0.5_Inact half-maximum inactivation potential, k Inact slope factor of inactivation. *P < 0.05 vs. control program in the ImageJ software. For signal quantification, fluorescence images of PLA and nucleus signals were converted to binary images by the triangle and minimum methods, respectively, using the ImageJ software [24, 34] . In each merged image, the number of pixels with PLA positive signals was normalized to that of pixels with nucleus signals by using ImageJ software.
Statistics
All data are expressed as means ± SEM. Statistical significance was evaluated using the unpaired Student's t test. For multiple comparisons of data were performed using ANOVA followed by Dunnett's or Bonferroni's test. A P<0.05 was considered statistically significant. All statistical analyses were performed using the SPSS software (SPSS Inc., Armonk, NY, USA).
Results
PDGF-induced VSMC migration by activating Ca V 1.2 Ca 2+ channels through c-Src/Abl tyrosine kinases A confluent monolayer of A7r5 cells was wounded and treated with vehicle or 10 ng/ml PDGF-BB for 48 h in a serum-free condition. Compared with the controls, PDGF-BB healed the wound significantly more intensely (Fig. 1a) , indicating that PDGF-BB promoted migration and/or proliferation of VSMC [26] [36] . Moreover, a Ca V 1.2 channel inhibitor, nifedipine (Sigma-Aldrich), almost completely inhibited PDGFinduced wound healing in a concentration-dependent manner in a range of concentrations between 0.1 and 3 μM (Fig. 1b) as reported previously [4] [21] . PDGF activates various intracellular signaling proteins [6] . Thus, the molecule(s) that mediated the effect of PDGF were examined. SFK/Abl inhibitor, bosutinib, (Sigma-Aldrich) exhibited a much stronger inhibitory effect on the PDGF-induced wound healing than a PI3K inhibitor, wortmannin, (Cayman Chemical, Ann Arbor, MI, USA); an ERK inhibitor, SCH772984 (AdooQ Bioscience, Irvine, CA, USA); a p38 kinase inhibitor, VX-702 (Tokyo Chemical Industry); or a protein kinase C (PKC) inhibitor, Gö6983 (Wako) (Fig. 1c-g ). Moreover, the effect of EHop-016, an inhibitor of an RFG, Rac1, was assessed; however, its strong cytotoxic effect precluded reliable analysis (data not shown). The fact that the proliferative PI3K and ERK played a minor role in the wound healing suggests that the result of this assay under the present condition mainly reflects the promigratory effect of PDGF. Thus, bosutinib inhibited PDGF-induced VSMC migration in a concentrationdependent manner (Fig. 1c) . Of note, nifedipine and bosutinib did not show any additivity in inhibiting PDGFinduced migration (Fig. 1h) , indicating that PDGF induced VSMC migration by activating Ca V 1.2 channels through SFK/Abl tyrosine kinases.
Direct evidence for PDGF-induced activation of Ca V 1.2 Ca 2+ channels through SFKs
The extracellular application of 60 mM K + increased intracellular Ca 2+ concentration much more strongly in PDGF-BB (10 ng/ml)-treated than that in control cells (Fig. 2a, b) . This effect of PDGF was almost completely inhibited by bosutinib (2 μM) (Fig. 2b) . However, PDGF-BB did not affect the expression level of Ca V 1.2 subunits nor c-Src (Fig. 2c, d) , indicating that the effect of PDGF on Ca V 1.2 channels was posttranslational. In mocktransfected cells, PDGF significantly increased Ca V 1.2 channel Ba 2+ currents in a range of the membrane potential between − 30 and + 30 mV (Fig. 2e) . However, this effect of PDGF was not observed in cells transfected with CSK, a selective inhibitor of SFK (Fig. 2e) . Therefore, PDGF increased the activity of Ca V 1.2 channels through SFK in VSMCs.
c-Src activates Ca V 1.2 Ca 2+ channels with full-length Ca V 1.2 by enhancing the coupling efficiency between VSD and AG Posttranslational modifications of Ca V 1.2 of VSMCs were assessed using immunoblotting (Fig. 3a) . Full-length Ca V 1.2 (Ca V 1.2FL) and Ca V 1.2 with truncated C-terminus at 1763 a.a. (Ca V 1.2Δ1763) were expressed in tsA201 cells and were immunoblotted as molecular markers of Ca V 1.2 without and with posttranslational modification, respectively. In synthetic A7r5 cells, most of the expressed Ca V 1.2 was fulllength (~240 KDa). In contrast, in contractile VSMCs in the rat aorta and cerebral artery and heart, both full-length and truncated Ca V 1.2 (~210 KDa) were expressed; these results are in agreement with those reported previously [1, 2, 5, 22] [ 23, 33] . These results suggest that PDGF induced the migration of A7r5 cells mainly by activating full-length Ca V 1.2.
Next, the effect of posttranslational modifications of Ca V 1.2 C-terminus on recombinant vascular Ca V 1.2 channels was examined. In this assay, tsA201 cells were transfected with cDNA for Ca V 1.2FL, Ca V 1.2Δ1763, or Ca V 1.2Δ1763 with clipped DCT together with cDNA for ancillary subunits β 2a and α 2 δ 1 (Fig. 3b) . The ratio of the ON gating charge of Ca V 1.2 channels elicited upon depolarization from − 80 mV to E rev and the amplitude of inward tail Ca V 1.2 channel Ba 2+ currents upon repolarization to − 70 mV (Fig. 3c, inset) was measured. This ratio reflected t h e c o u p l i n g e ff i c i e n c y b e t w e e n V S D a n d A G . Ca V 1.2Δ1763 channels showed a significantly higher ratio than Ca V 1.2FL channels, whereas Ca V 1.2Δ1763 channels coexpressed with clipped DCT (Ca V 1.2Δ1763 + DCT) exhibited a significantly smaller ratio than Ca V 1.2Δ1763 channels (Fig. 3c) . These results indicate that both BinternalD CT in Ca V 1.2FL and Bclipped^DCT associated with Ca V 1.2Δ1763 autoinhibited vascular Ca V 1.2 channel activity.
Further, effects of coexpression of c-Src on three types of Ca V 1.2 channels were assessed. Interestingly, c-Src significantly increased the coupling efficiency of Ca V 1.2FL channels, did not further increase that of Ca V 1.2Δ1763 channels, and had no significant effect on Ca V 1.2Δ1763 + DCT channels (Fig. 3d) . c-Src significantly increased the Ca 2+ current density of Ca V 1.2FL channels in a range of the membrane potentials between − 20 and + 30 mV (Fig. 3e) . However, cSrc did not affect the voltage-dependency of steady-state activation or inactivation of Ca V 1.2FL channels (Fig. 3f, Table 1 ).
Whether the failure of c-Src to activate Ca V 1.2Δ1763 + DCT channels may be attributed to the overexpression of DCT compared with Ca V 1.2Δ1763 in tsA201 cells and thus, very strong inhibition of the channel activity was examined. This may be because of the smaller nucleotide number and the consequent more efficient transcription of cDNA for DCT than that for Ca V 1.2Δ1763. However, different molar ratios of cDNA of DCT and Ca V 1.2Δ1763 failed to enable c-Src to activate Ca V 1.2Δ1763 + DCT (Fig. 3g) . In contrast, CK2α'β significantly activated Ca V 1.2Δ1763 + DCT but not Ca V 1.2FL channels (Fig. 3h) . These results strongly suggest that Ca V 1.2 channels with full-length Ca V 1.2 or truncated Ca V 1.2 associated with clipped DCT were both autoinhibited but were not functionally identical and subjected to differential regulations.
c-Src can bind to and phosphorylate full-length Ca V 1.2 channels
To elucidate the molecular mechanism underlying the selective effect of c-Src on Ca V 1.2FL, the phosphorylation of Ca V 1.2FL, Ca V 1.2Δ1763, and Ca V 1.2Δ1763 + DCT by (Fig. 4a-c) .
Next, the interaction between c-Src and three types of Ca V 1.2 channels was assessed by an in situ PLA. This assay visualizes the interaction of two proteins identified by two specific antibodies. This assay indicated that c-Src was significantly closer to Ca V 1.2FL channels than to Ca V 1.2Δ1763 or C a V 1 . 2 Δ 1 7 6 3 + D C T c h a n n e l s ( F i g . 4 d , e ) . Immunocytochemistry using the same antibodies used for PLA indicated that there was no statistical difference in expression levels of Ca V 1.2FL, Ca V 1.2Δ1763, and Ca V 1.2Δ1763 + DCT (data not shown). These results indicate that c-Src selectively activates Ca V 1.2FL channels because it can associate with and thus phosphorylate Ca V 1.2FL more efficiently than Ca V 1.2Δ1763 irrespective of the presence or absence of DCT. (Fig. 5a ). The C-terminus was first divided into PCT and DCT, and all tyrosine residues in PCT and DCT were mutated to phenylalanine residues (Fig. 5b) . Mutations in PCT but not DCT completely inhibited the effect of c-Src on the coupling efficiency of Ca V 1.2FL channels (Fig. 5b) . Next, PCT was divided into proximal PCT (PPCT) and distal PCT (DPCT), and all tyrosine residues in PPCT and DPCT were mutated to phenylalanine residues. The results of analysis of c-Src on these channels indicated that tyrosines in DPCT but not PPCT participated in the activation of Ca V 1.2 channels by c-Src (Fig. 5b) . Finally, each tyrosine residue in DPCT was individually mutated to phenylalanine, which confirmed that c-Src activated Ca V 1.2FL channels by phosphorylating Tyr 1709 and Tyr 1758 in DPCT of Ca V 1.2FL channels (Fig. 5c ).
Discussion
The present study confirmed for the first time that PDGF induces the migration of synthetic VSMCs by activating Ca V 1.2 channels with full-length Ca V 1.2 through SFK.
Synthetic VSMCs represented by A7r5 cells expressed mainly full-length Ca V 1.2, but contractile VSMCs in vivo expressed both full-length and truncated Ca V 1.2. In assays using recombinant vascular Ca V 1.2 channels, c-Src could bind to and phosphorylate full-length Ca V 1.2 more efficiently in comparison to truncated Ca V 1.2 in the presence or absence of DCT. Moreover, c-Src activated Ca V 1.2 channels by phosphorylating Tyr 1709 and Tyr 1758 in the PCT of full-length Ca V 1.2. These results confirmed that phenotypic switching of VSMCs in atherosclerotic lesions may increase the ratio of full-length to truncated Ca V 1.2 channels and thereby facilitate PDGF-induced migration of VSMCs.
Among versatile signal transduction pathways activated by PDGFR, SFK, PI3K, MAPK, and RFG are implicated to play a role in cell migration [11] . However, we observed that SFK exerted much stronger pro-migratory effect on A7r5 cells than PI3K, MAPK, or PKC (Fig. 1) . In addition, we observed that the PDGF-induced migration of A7r5 cells was strongly dependent on Ca V 1.2 channel activity. The effects of an SFK inhibitor, bosutinib, and a Ca V 1.2 channel inhibitor, nifedipine, did not exhibit additive effect, indicating that PDGF activated Ca V 1.2 channels through SFKs. In cell migration, intracellular Ca 2+ plays a crucial role [15, 31] . In migrating cells, Ca V 1 channels evoke Ca 2+ sparklets at the rear end. This channel activity increases intracellular Ca 2+ concentration and causes actomyosin contraction to retract the trailing tail [18] . However, the mechanism through which SFK activate only Ca V 1.2 channels at the rear end of migrating VSMCs remains unclear. Recently, Kim et al. have reported that chemotactic signal (local epidermal growth factor receptor stimulation) at the front edge of human umbilical endothelial cells activated the whole-cell Ca V 1 channels through PI3K, whereas PKC more strongly inhibited Ca V 1 channels closer to the receptors at the front edge [18] . Because in our case, inhibitors of PI3K and PKC were not effective, different mechanism(s) may underlie the localized activation of Ca V 1.2 channels in VSMCs.
In a heterologous expression system, c-Src activated Ca V 1.2FL channels by enhancing the coupling efficiency between VSD and AG. This indicated that c-Src inhibited the autoinhibitory effect of DCT in Ca V 1.2FL. This effect of c-Src was mediated by the phosphorylation of Tyr 1709 and Tyr 1758 in PCT. Different from PKA, c-Src did not shift the activation curve of Ca V 1.2 channels in the hyperpolarizing direction. This is probably because of different amino acid residues phosphorylated by these kinases. It is also possible that different modes of action of PKA and c-Src may account for the difference: PKA activates Ca V 1.2 channels composed of truncated Ca V 1.2 and clipped DCT whereas c-Src activates Ca V 1.2FL channels. Tyr 1709 and Tyr 1758 in PCT are novel regulatory sites identified in this study. Kang's previous study on the human vascular Ca V 1.2-b has indicated that c-Src first phosphorylates Tyr 2134 of Ca V 1.2, recognizes this ; n = 5-11 cells in each ratio. There was no statistically significant difference between mock and c-Src groups at any molar ratios. h Effect of CK2α'β overexpression on coupling efficiencies of Ca V 1.2FL and Ca v 1.2Δ1763 + DCT channels in tsA201 cells; n = 6-9. *P < 0.05 versus each mock phosphotyrosine with its own SH2 domain, and then phosphorylates Tyr 1837 of Ca V 1.2 to activate Ca V 1.2 channels [16] . Of these two sites, Tyr 2134 corresponds to Tyr 2136 in our B8 clone, whereas Tyr 1837 is replaced with serine in our B8 clone. The reason for the discrepancy between our and Kang's results remains unclear, but this could be attributed to various possibilities. First, Kang's analysis was restricted to DCT; thus, the effects of phosphorylation of tyrosine residues in PCT might have been overlooked. Second, a slight and insignificant decrease in the effect of c-Src on Ca V 1.2FL DCT-YF compared with that on Ca V 1.2FL (Fig. 5b) c-Src significantly activated Ca V 1.2FL channels but not Ca V 1.2Δ1763 or Ca V 1.2Δ1763 + DCT channels (Fig. 3d) . As mentioned above, it was likely that c-Src activated Ca V 1.2FL channels by inhibiting the autoinhibitory effect of DCT. It is, therefore, plausible that c-Src might not further activate un-autoinhibited Ca V 1.2Δ1763 channels. However, it was puzzling why c-Src did not activate autoinhibited Ca V 1.2Δ1763 + DCT channels. We first considered a possibility that in our construct, DCT may be overexpressed in comparison with Ca V 1.2Δ1763 in tsA201 cells and thereby caused very strong inhibition on the channel activity. However, this was not the case because a wide range of DCT-to-Ca V 1.2Δ1763 cDNA molar ratios did not enable c-Src to activate Ca V 1.2Δ1763 + DCT channels (Fig. 3g) . Therefore, we suggest that Ca V 1.2 channels became unresponsive to c-Src irrespective of the degree of autoinhibition once its Ca V 1.2 C-terminus was clipped. Interestingly, CK2 efficiently activated Ca V 1.2Δ1763 + DCT channels (Fig. 3h) , but it failed to activate Ca V 1.2FL channels. We also observed the same results regarding the differential regulation of cardiac Ca V 1.2 channels by c-Src and CK2 [17] . These results strongly suggest that Ca V 1.2 channels with full-length Ca V 1.2 and those with truncated Ca V 1.2 associated with clipped DCT were both autoinhibited but were not functionally identical and subjected to differential regulations.
Our results indicate that c-Src can more efficiently bind to and phosphorylate Ca V 1.2FL than Ca V 1.2Δ1763 or Ca V 1.2Δ1763 + DCT channels (Fig. 4) . It was proposed that c-Src binds to the proline-rich domain (PRD) in DCT via its SH3 domain (Fig. 6) [10] [16] . Thus, cSrc would not be able to bind to Ca V 1.2Δ1763 because it is devoid of PRD. It is also suggested that cleaved DCT associates with PCT via the same PRD [10] . Thus, we propose that c-Src cannot activate Ca V 1.2Δ1763 + DCT channels because the binding of c-Src to PRD in clipped DCT is precluded by the putative PRD acceptor site(s) (PAS) in PCT (Fig. 6) . Namely, Ca V 1.2Δ1763, DCT, and c-Src may not form a ternary complex. In Ca V 1.2FL channels, DCT may not noncovalently bind to internal PCT via the PRD; thus, c-Src may be able to bind to PRD. Notably, c-Src weakly but unmistakably interacted with and phosphorylated Ca V 1.2Δ1763 + DCT channels (Fig. 4) . This interaction may arise from the interaction of c-Src with another PRD in the intracellular loop between domains II and III of Ca V 1.2 [7] . However, our study did not delineate the functional significance of this phosphorylation.
To summarize, our findings demonstrate that PDGF induces the migration of synthetic VSMCs by activating The coupling efficiency of Ca V 1.2FL channels in which all tyrosine residues were mutated to phenylalanine within the indicated regions of Ca V 1.2CT. c The coupling efficiency of Ca V 1.2FL channels in which tyrosine residues were individually mutated to phenylalanine; n = 5-15 cells. *P < 0.05 versus each mock Ca V 1.2 channels with full-length Ca V 1.2 through SFK. Moreover, in contrast to contractile VSMCs, synthetic VSMCs express full-length Ca V 1.2 more strongly than truncated Ca V 1.2. It is possible that contractile VSMCs are less migratory than synthetic VSMCs at least in part because the substantial fraction of Ca V 1.2 in contractile VSMCs is converted into the truncated form. Clipped DCT enters the nucleus and serves as a transcriptional factor [12] , suppressing the transcription of Ca V 1.2 gene in cardiac myocytes and VSMCs [2, 27] . Thus, when VSMCs undergo a phenotypic switching in atherosclerotic lesions, the inhibition of posttranslational modification of the C-terminus of Ca V 1.2 may increase the ratio of full-length Ca V 1.2 to truncated Ca V 1.2 and enhance the transcription of Ca V 1.2 per se. We posit that such phenotypic switching may coordinately facilitate the pro-migratory effects of PDGF on VSMCs. 
